by Ellie Lampton | Jul 8, 2024
In the largest comparative effectiveness study of tirzepatide (Mounjaro) and semaglutide (Ozempic) for weight loss using real-world data – now published in JAMA Internal Medicine – Truveta Research found that patients with overweight or obesity taking tirzepatide were...
by Ellie Lampton | Jun 17, 2024
With industry-leading certifications and rigorous third-party audits, Truveta announces new capabilities to enable successful regulatory submissions and audits. BELLEVUE, Wash. – June 18, 2024 – Today, Truveta announced regulatory and audit capabilities to support its...
by Ellie Lampton | May 13, 2024
BELLEVUE, Wash. – May 13, 2024 – Today Truveta, a growing collective of more than 30 health systems with a mission of Saving Lives with Data, welcomes Rod Hochman, MD, president and CEO of Providence, as its new Board of Directors Chair. Truveta’s Board of Directors...
by Ellie Lampton | May 2, 2024
From detailed family history and complex concepts from a wide range of therapeutic areas to millions of de-identified medical images, Truveta empowers researchers with the most complete, timely, and clean data. BELLEVUE, Wash. – May 2, 2024 – Today Truveta announced...
by Ellie Lampton | Apr 25, 2024
BELLEVUE, Wash. – April 25, 2024 – Truveta, the company with a mission of Saving Lives with Data, announced today the largest and most complete mother-child electronic health record (EHR) dataset for scientifically rigorous research on mothers and their children....
